The adult prostate possesses a significant regenerative capacity that is of great interest for understanding adult stem cell biology. We demonstrate that leucine-rich repeat-containing G protein-coupled receptor 5 (Lgr5) 
INTRODUCTION
The secretory prostate organ requires androgen signaling both for development and for proper maintenance of structure and function. Although the adult homeostatic prostate is a predominantly quiescent organ, it harbors a tremendous regenerative capacity that allows it to undergo multiple rounds of androgen-mediated involution and regeneration. Understanding this profound capacity for adult prostate tissue renewal is of great interest for elucidating stem cell biology and may also provide insight into disease.
Unlike the human prostate, which is organized into a single lobe with varying zonal layers, the murine prostate has four distinct lobes surrounding the urethra. The adult prostate contains three epithelial lineages, i.e., basal, luminal, and neuroendocrine cells (Karthaus et al., 2014; Marker et al., 2003; Wang et al., 2014b) . Luminal cells are columnar androgen-receptor-positive cells that are identified by the cytokeratin markers CK8 and CK18. Basal cells reside adjacent to the luminal cells and express the markers CK5, P63, and CK14. Upon androgen deprivation via castration, 90% of luminal cells undergo apoptosis; however, the luminal cells can be rapidly regenerated following readministration of testosterone, suggesting the existence of stem cells and their important role in prostate regeneration (Choi et al., 2012; Goldstein et al., 2008; Tsujimura et al., 2002) . Many hypotheses have been suggested to explain the regenerative process of the adult prostate. Previous work has established that stem cells within the basal compartment divide asymmetrically, generating one stem cell and one committed progenitor cell that differentiates to ultimately yield a luminal or neuroendocrine cell during prostate postnatal development (Ousset et al., 2012; Pignon et al., 2013) . However, some studies have described multipotency for both luminal (Wang et al., 2009 ) and basal (Wang et al., 2014a) cells following castration-induced involution, while others have supported committed lineage-specified progenitors for luminal and basal cells during adult prostatic regeneration (Choi et al., 2012; Liu et al., 2011) . In addition, an intermediate cell phenotype that is both CK5 + and CK18 + has been reported (Xue et al., 1998) .
During development, prostate expansion is regulated by Wnt signaling (Isaacs and Coffey, 1989; Marker et al., 2003; Wang et al., 2008) . The Wnt pathway is highly activated during early stages of prostate development, as well as during prostate regeneration. The Wnt-regulated gene Lgr5 has been shown to serve as a stem cell marker in several adult tissues, including the ovary, mammary gland, intestinal tract, and hair follicle (Barker et al., 2007; Jaks et al., 2008; Ng et al., 2014; Plaks et al., 2013; Rios et al., 2014) .
Here, we investigated the possibility that (legend continued on next page) ventral, and anterior) and within the stroma of the ventral lobes of the mouse prostate.
Lgr5
+ Cells Are Castration Resistant
To determine the androgen dependency of Lgr5 + cells, we castrated adult LT mice, allowed them to regress for 4 weeks, and then pulse labeled them for 4 consecutive days prior to terminal tissue assessment ( Figure 2A ). We identified a castration-resistant subpopulation of Lgr5 + cells in the fully regressed prostate (Figures 2B-2E ). Sporadic Lgr5 + cells comprised only 0.068% of total cells in the anterior lobes of the fully regressed mouse prostate ( Figure 2B ). Moreover, Lgr5 mRNA levels did not decrease in 6-week castrated, regressed prostates compared with intact prostates (Figure 2C Tamoxifen-mediated labeling in fully regressed prostates and subsequent testosterone-mediated prostate regeneration revealed ribbons (defined as three or more cells) of labeled cells (Figures 2F and 2G) . Quantification of labeled cells demonstrated a 28-fold expansion following the first round of regeneration (0.068% in first-round fully regressed prostates to 1.942% after the first round of regeneration; Figure 2B ). Following a second round of regression ( Figures 2H and 2I ), the labeled castration-resistant cells were frequently clustered as doublets, and twice as many labeled cells were identified compared with the first round of regression (round 1: 0.068%; round 2: 0.156%; Figure 2B ). When the cells were allowed to regenerate a second time (Figures 2J and 2K) , a 29-fold expansion of labeled cells between fully regressed and regenerated prostates was observed (0.156% in round 2 regressed to 4.60% in round 2 regenerated prostates; Figure 2B ). Figure 3A ). In the regenerated state, the average number of labelpositive cells per unit increased to 6 and 10 cells per unit for first and second rounds of regeneration, respectively ( Figure 3A ). The labeled units were comprised of basal and/or luminal cells, and the numbers of these cells did not decrease on a per-unit basis during the two rounds of regression and regeneration ( Figures 3B and 3C ). In fact, the labeled luminal population doubled in the regressed setting between the first and the second round of regression, suggesting that a subset of Lgr5 + cell progeny may also be castration resistant ( Figure 3B ). Further analysis of the label-positive cells from the first round of regression and regeneration revealed that 70% of the labeled units were of the luminal cell type only ( Figure 3D ). In contrast, the average number of basal cells per unit was less than one, and no ribbons (defined as three or more cells) of purely basal cells were observed in either regressed or regenerated prostate ( Figure 3C ). These findings indicate that the majority of labeled basal Lgr5 + cells do not give rise exclusively to basal cell progeny during the first round of prostate regeneration, which is consistent with limited loss of basal cells and extensive loss of luminal cells upon androgen deprivation. Overall, the data show that cell expansion from Lgr5 + cells occurs mostly in the luminal cell compartment during regeneration.
(H and I) Immunofluorescent images of Lgr5 + (RFP + ) progeny (red) and CK5 (green) in anterior lobes of round 2 (R2) regressed prostates. Labeled cells were observed in both the basal (H) and luminal (I) compartments. (J and K) Immunofluorescent images of Lgr5 + (RFP + ) progeny (red) and CK5 (green) in anterior lobes of round 2 regenerated prostates. Labeled cells were exclusively in the luminal compartment (J) or in both the luminal and basal compartments, arrows (K). All values are presented as mean and SEM. testo, testosterone; n, number of mice; cn, number of cells counted. *p < 0.05, ***p < 0.001. See also Figure S1 .
Since we found Lgr5
+ cells within both the basal and luminal compartments upon prostate regression, we sought to elucidate whether they were giving rise to progeny in a uni-or bipotent manner. Label-positive units were found to be composed of luminal cells only, basal cells only, or mixed units containing both luminal and basal cells. Seventy-four percent of the units contained only luminal cells, and the percentage of luminal-only units did not change significantly during regeneration ( Figure 3D ), indicating that the majority of luminal Lgr5 + cells at castrated stages were unipotent. However, the percentage of basal-cellonly units dropped following the first round of regeneration (round 1: 21.2% in the regressed prostate versus 1.6% in the regenerated prostate; Figure 3E ). In contrast, the percentage of mixed units increased following regeneration (round 1: 5.1% in the regressed prostate versus 23% in the regenerated prostate; Figures 3F and 3G ). Notably, in the second round of regression and regeneration, we observed a similar trend, i.e., the percentage of luminalonly units did not change. However, the basal-cell-only units significantly decreased (round 2: 12.6% in the regressed prostate versus 0% in the regenerated prostate) and total number of units counted (uc): R1 regressed, n = 3, uc = 33; R1 regenerated, n = 11, uc = 150; R2 regressed, n = 7, uc = 84; R2 regenerated, n = 5, uc = 121. Units counted per mouse = 9-43. All values are represented as mean and SEM; n.s., not significant; **p < 0.01, ****p < 0.0001. See also Figure S2 . and the mixed units significantly increased (round 2: 17.2% in the regressed prostate versus 36.1% in the regenerated prostate) during the second round of regeneration ( Figures  S2B-S2D ). The presence of mixed units (Figures 2G, 2K, S2D, and S2E) Figures 6A-6C ). These data suggest that depletion of Lgr5 + cells leads to altered luminal cell differentiation and expansion, and impaired prostate regeneration. Gene expression analysis further revealed that cluster of differentiation 31 (CD31), vascular endothelial growth factor receptor 1 (VEGFR1), and Wnt pathway target genes (e.g., b-catenin and Axin 2) were significantly elevated in Lgr5-depleted prostates ( Figure 6D ). This expression profile is reminiscent of an earlier stage (days 1-3) of prostate regeneration (Wang et al., 2007 However, we cannot exclude the possibility that a small portion of luminal Lgr5 + cells can also be bipotent in situ.
Previous work has established that stem cells within the basal compartment divide asymmetrically, generating one stem cell and one committed progenitor cell that differentiates to ultimately yield a luminal or neuroendocrine cell during prostate postnatal development (Ousset et al., Pignon et al., 2013) . However, there is some controversy about the cellular hierarchy that governs adult prostate regeneration following castration-induced involution. Some studies have described multipotency for both luminal (Wang et al., 2009 ) and basal (Wang et al., 2014a ) cells, and others have supported committed lineage-specified progenitors for both luminal and basal cells during adult prostatic regeneration (Choi et al., 2012; Liu et al., 2011 (Choi et al., 2012; Wang et al., 2013 Wang et al., , 2014b . This is consistent with recent work that identified multipotent basal and luminal cells in a human organoid culture system (Karthaus et al., 2014 
2012;

EXPERIMENTAL PROCEDURES
Animals
E18 pregnant rats and athymic nu/nu male mice at 8 weeks of age were purchased from Harlan Sprague Dawley. Lgr5 DTR.EGFP and
Lgr5
CreER mice were generated as previously described (Tian et al., 2011) . Lgr5 CreER mice were interbred with the Rosa26.LSL.tdTomato mouse line to generate Lgr5
CreER ;Rosa26.LSL.tdTomato (LT) mice. The animals were dosed and monitored according to the guidelines of the Institutional Animal Care and Use Committee (IACUC) at Genentech.
Antibodies
The following antibodies were used: CK5 (1:1,000, PRB-160P; Covance), P63 (1:600, clone 4A4; Santa Cruz Biotechnology), CK8 (1:1,000, MMS-162P; Covance), CK18 (1:500, ab82254; Abcam), Ki67 (1:200, RM-9106; Thermo Scientific), anti-BrdU (1:1,000, #347580; Becton Dickinson), and Alexa Fluor 488 donkey anti-rabbit IgG (H+L, 1:500, A-21206; Life Technologies).
Castration, Tamoxifen Labeling, and Prostate Regeneration
Surgery was conducted using aseptic procedures. Following preparation of the surgical site, an incision was made in the scrotum. Then an incision was made in the tunica of the first testicle. The testis, vas deferens, and attached testicular fat pad were pulled out of the incision. The blood vessels supplying the testis were cauterized. The testis, vas deferens, and fatty tissue were severed just below the site of cauterization. The tunica on the contralateral side was similarly penetrated and the procedure was repeated. The scrotum incision was closed with a 4-0 absorbable Vicryl suture. Four weeks after castration, LT mice were administered tamoxifen at 5 mg/20 g, or corn oil by oral gavage daily for four consecutive days. A 12.5 mg/pellet/mouse testosterone pellet was implanted 2 weeks after the last dose of tamoxifen.
Renal Capsule Grafting and Testosterone Pellet Implantation
Animals were anesthetized using ketamine/xylazine. The back of the skin (dorsal midline over the lumbar) was prepped with povidone iodine and 70% ethanol. The back skin was lifted with a pair of blunt forceps and a lumbar incision was made with a pair of scissors, creating an incision approximately 1 inch long. The animal was placed on its side and a small incision was made in the body wall just along the long axis of the kidney. A pair of fine forceps (#5) was used to gently pinch and lift the capsule from the parenchyma of the kidney so that a 2-4 mm incision was made in the capsule with fine spring-loaded scissors. Grafts were transferred to the surface of the kidney using forceps. The body wall was closed with a 4-0 Vicryl suture. A testosterone pellet (12.5 mg/pellet, one pellet/mouse) was placed between the body wall and skin. After grafting, the edges of the back skin were aligned and closed with a 4-0 absorbable Vicryl suture.
UGM Preparation
UGM cells were dissociated from embryonic day 18 (E18) embryos from pregnant Sprague Dawley rats as described previously (Leong et al., 2008; Marker et al., 2003; Tsujimura et al., 2002) . Briefly, UGM cells from E18 embryos were dissociated with 1 mg/ml of collagenase/dispase (Roche) in DMEM plus 10% fetal bovine serum (FBS), 2 mM glutamine, and 100 U/ml of penicillin and streptomycin for 1 hr at 37 C. UGM cells were cultured in DMEM with 10% FBS, 2 mM glutamine, 10 mg/ml insulin, 5.5 mg/ml transferrin, 6.7 ng/ml selenium, 1 nM testosterone (Innovative Research of America), 100 U/ml penicillin, and 100 mg/ml streptomycin. UGM cells were passaged with trypsin twice and used within 7 days after tissue dissociation.
Flow Cytometry
Five to eight prostates were harvested and pooled together for one FACS sorting or analysis experiment. Prostate cells were dissociated as described previously (Leong et al., 2008; Taylor et al., 2010; Wang et al., 2009 ). Cells were non-lineage depleted using a mouse lineage cell depletion kit Miltenyi Biotec) , stained with propidium iodide (PI), and analyzed on an LSR-II flow cytometer (Becton Dickinson). Single cells were sorted into individual wells of U-bottom 96-well plates containing 20 ml of collagen type I by an LSR-II flow cytometer (Becton Dickinson), and confirmed with an inverted Olympus Ix81 microscope.
DT Treatment and BrdU Labeling In Vivo
Adult male mice were castrated and 4 weeks later were implanted with a testosterone pellet (as described above) administered concurrently with DT (catalog #322326; EMD) at 50 ng/g, intraperitoneally (i.p.). The DT treatment was administered every other day, for a total of four times. BrdU (550891; BD PharMingen) was administered at 200 ml/mouse, 10 mg/ml, i.p., 16 hr before the mice were euthanized. The mice were euthanized and prostates were harvested on day 9 after the first DT treatment.
Immunohistochemistry and Image Acquisitions
Prostates were fixed with 4% paraformaldehyde for 2-3 hr on ice, followed by 30% sucrose overnight at 4 C, embedded in OCT, and sectioned at 5-6 mm. Sections were blocked with 10% normal goat or donkey serum for 1 hr at room temperature, incubated with primary antibodies over night at 4 C, followed by secondary antibody incubation for 30 min at room temperature. Serial sections of each mouse prostate were observed and imaged on either a Zeiss Axioplan 2 imaging microscope with an ORCA-ER digital camera (Hamamatsu), or on Olympus BX61 upright microscope. Or, whole slide images were acquired by the Ariol SL-50 automated slide scanning platform (Leica Microsystems) at 1003 final magnification using standard fluorescence filters. Scanned slides were analyzed in the MATLAB software package (version R2012b; The MathWorks). Individual cell nuclei were segmented using a radial symmetry based method applied to the DAPI channel (Veta et al., 2013) and then scored for the presence of CK5, CK18 signal above a global intensity threshold in the area immediately surrounding each nucleus.
RNA Extraction
Tumor samples were placed into RNALater (Ambion) at 4 C for $24 hr. Then, 30 mg of tissue was excised from the total tissue collected and total RNA was extracted with the QIAGEN AllPrep Kit (QIAGEN) following the manufacturer's protocol. RNA quantity was determined using Nanodrop (Thermo Scientific) and the quality was assessed by Agilent 2100 Bioanalyzer (Agilent Technologies) according to the manufacturers' protocol.
RNA Reverse Transcription
The 20 ml reverse transcription reaction contained 10 ml of 10 ng/m of total RNA, 2 ml of 103 RT buffer, 0.8 ml of 100 mM dNTPs, 2 ml of 103 RT Random Hexamer Primers; 1 ml of RNase inhibitor (20 U/ml), 1 ml of Multiscribe Reverse Transcriptase (50 U/ml), and 3.2 ml of H 2 O. All reagents were purchased from Applied Biosystems (part number 4374966). The reaction mixture was mixed with the RNA and incubated as follows; 25 C for 10 min, 37 C for 120 min and then 85 C for 5 min.
Preamplification of cDNA
A total of 96 TaqMan assays (Life Technologies) were pooled at a final concentration of 0.23 for each assay. Pre-PCR amplification reaction was done at 5 ml containing 2.5 ml TaqMan PreAmp Master Mix (23, part number 4391128), 1.25 ml of 96-pooled TaqMan assay mix (0.23) and 1.25 ml of cDNA from the reverse transcription reaction described above. The pre-amplification PCR was incubated as follows: one cycle at 95 C for 10 min, and 14 cycles at 95 C for 15 s and then at 60 C for 4 min. After preamplification PCR, the product was diluted 1:5 with TE buffer (Ambion, part number 9849) and stored at À80 C until needed.
RNA Expression Analysis Using a 96.96 Dynamic Array
Reverse transcription and preamplification were performed as described above. Quantitative PCR was carried out using the 96.96 dynamic array platform (Fluidigm) following the manufacturer's protocol. Specifically, a 6 ml sample mixture was prepared for each sample containing 3 ml of TaqMan Universal Master Mix (part number 4304437), 0.3 ml of Sample Loading Reagent (part number 85000746) and 2.7 ml of diluted, preamplified cDNA. A 6 ml assay mixture was prepared with 3 ml of each TaqMan assay and 3 ml of Assay Loading Reagent (part number 85000736). An Integrated Fluidic Circuit (IFC) controller was used to prime the 96.96 Dynamic Array IFC chip with control line fluid, and 5 ml of both the sample and assay mixes were loaded into the appropriate inlets. After loading, the chip was placed in the BioMark Instrument for PCR at 95 C for 10 min, followed by 40 cycles at 95 C for 15 s and 60 C for 1 min. The data were analyzed with Real- LGR5 expression in normal prostate tissue (n=43), prostate tumors (n=247) and three prostate cancer cell lines from RNA sequencing, n= patients.
Supplemental Experimental Procedures
RNA sequencing
The transcriptome data in TCGA was profiled as follows: the RNA-seq data was processed by our GSNAP-based 1 transcriptome analysis pipeline, HTSeqGenie 2 . Gene expression was quantified with RPKM values (reads mapping to a gene per kilobase of transcript per million reads sequenced).
